2023 Sotoracib (AMG510) Latest Price Updates

As an innovative targeted therapy, sotoracib (AMG510) has a significant effect in the treatment of cancers with KRAS G12C mutations. KRAS G12CMutations are commonly found in various cancers such as lung cancer and colorectal cancer. The development of this drug undoubtedly provides new hope for refractory cancers.

Since sotoracib has not yet been officially approved in the country, domestic patients cannot purchase it directly. However, they have access to the drug through international channels. In the international market, there are two types of sotoraxib: original drugs and generic drugs.

Original drugs, including the European version and the Hong Kong version, are expensive, usually in the range of hundreds of thousands of yuan. This price is a financial challenge for many patients.

In contrast, generic drugs already on the market in foreign markets appear to be more economical. For example, the prices of generic drugs produced by Lao Lucius and Lao Big Bear have been significantly adjusted recently. Now patients only need to pay about more than one thousand to more than two thousand yuan. This undoubtedly greatly alleviates the financial pressure on patients and makes this drug more accessible.

Importantly, there is no significant difference in core ingredients between original drugs and generic drugs. Therefore, when patients choose a drug, they can consider it more based on price without having to worry too much about the quality of the drug.

In summary, even though sotorasibu has not yet been approved domestically, patients still have the opportunity to obtain it through international channels. Although original drugs are expensive, generic drugs on the foreign market provide patients with a more economical choice, thereby lowering the economic threshold for treatment and bringing new hope to patients.